Indolent prostate cancer and active surveillance Sue Mayor 1 January 2010 Grandround 0 Number 34 Download pdf article Early aggressive treatment in patients whose cancer is likely to progress slowly, if at all, causes side-effects and reduces their quality of life for no benefit. Can active surveillance avoid this? Download full article active surveillanceprostate cancer
Past events Rome (Italy), 25-26/11/2016 – Molecular Diagnostics, Genomics and Epigenetics in Clinical Oncology Past events 26 October 2016 0
